|
Patients-care
|
|
greetings
|
|
Dear friends,
I am a practicing physician, M.D., Medicine from Kanpur medical College, India, having my own nursing home in Delhi. It had been my long cherished dream to develop a software which could be called as clinician’s companion in true sense & help them in every respect to write a safe, fool proof & first rate prescription. After 10 years of hard work I think the dream has become reality now with the development of a prescription writing software called “PRESCRIPTION PAD”.
Prescription writing is not merely putting few drug names on a piece of paper rather it is an art which can be attained only after years of experience, hard work & sound knowledge of the basic subject. World over, there is stress on evidence based medicine which can be described as “the conscientious, explicit & judicious use of current best evidence in making decisions”. Professional organizations & government agencies are developing formal clinical practice guidelines in an effort to aid physicians & other caregivers in this endeavor. These guidelines can provide a useful framework for managing patients with particular diagnosis or symptoms. The challenge for the physician is to integrate into clinical practice the useful recommendations offered by the experts who prepare clinical practice guidelines without accepting them blindly or being inappropriately constrained by them.
A report from the Institute of Medicine, USA concluded that “to err is human” but called for an ambitious agenda to reduce medical error rates & improve patient safety by designing & implementing fundamental changes in health care system. Accordingly it is the responsibility of hospitals & health care organizations to develop systems to reduce risk & ensure patient safety.
We have designed our software on these general guidelines. The software at the moment has a database of more than 40,000 brands with full prescribing information, full information about nearly 24,00 drugs with their complete monographs to backup, information about 1500 diseases, their differential diagnosis, investigatory workup, many treatment guideline & protocols & other important pointers along with patients education material. The software automatically checks for drug interactions & drug safety for children & elderly, pregnancy, lactation, liver insufficiency, renal insufficiency, pulmonary insufficiency & gives you warning in case of any untoward effect. The software has capability of giving you useful pointers also from time to time while writing prescription. The software checks for the drug safety at the individual disease level too e.g. it gives you warning if any drug is not safe to give in PORPHYRIA or G6PD disease or in diabetes. In this way the software tries to ensure that you give out 100% safe, first rate & fool proof prescription to a patient by providing you all the related information automatically.
The complete details of the software features can be seen on the website www.prescriptionpad.in .
Drug interactions & drug safety is major issue in prescription writing especially in multi-organ diseases where large number of drugs are prescribed. In such situations this software can be very useful.
I am giving some common examples of drug interactions in day-to-day practice :
Ace inhibitors with Aspirin Reduces hypotensive effects of ace inhibitors
Quinolones with Nsaids CNS excitation
Eltroxin with Iron Poor absorption of Eltroxin
Zinc with Iron & other minerals
Quinolones,
Tetracyclines Poor absorption
Antacids with Antibiotics Poor absorption /chelation
The usefulness of the software is realized only when you start using it & I am sure it would encourage more & more clinicians to use computers & may change the way doctors write prescription in future.
Regards
Dr anil vij
|
|
post a Comments
|
|
|
|
|
No-Entry Zones for AIDS Virus
|
|
The AIDS virus inserts its genetic material into the genome of the infected cell. Scientists of the German Cancer Research Center have now shown for the first time that the virus almost entirely spares particular sites in the human genetic material in this process. This finding may be useful for developing new, specific AIDS drugs.
Like all retroviruses, the AIDS virus (HIV) integrates its DNA into the genome of the infected cell. As integration sites, HIV usually prefers active genes that are transcribed frequently. This is advantageous for the virus, because this is where it finds large amounts of enzymes which are responsible for transcription. The virus abuses this cellular equipment for its own replication.
|
|
post a Comments
|
|
|
4 private hospitals may get nod to treat swine flu patients
|
|
Delhi government is all set to give a go-ahead to four private hospitals to admit H1N1 influenza patients by this weekend. The state health department has inspected the isolation wards at Indraprastha Apollo, Moolchand Medcity, Sir Gangaram and St Stephens and are in the process of discussing the H1N1 influenza protocols that needs to followed while treating positive cases.
|
|
post a Comments
|
|
|
Scientists trying to identify 'sanjivani' herb
|
|
Having found a few Himalayan herbs that match the description of the sanjivani, a team of five scientists at the National Botanical Research Institute (NBRI) here is working on identifying the properties of each of these.
'We are engaged in a genetic analysis of these herbs to zero in on what we are looking for in a true sanjivani herb,' team leader P.N. Khare told IANS.
What has made the task difficult is the lookalike features of several different herbs found at high altitudes in the Himalayas from where monkey god Hanuman is understood to have fetched the herb to save the life of Lakshman who was injured in battle.
|
|
post a Comments
|
|
|
European Medicines Agency Recommends Authorisation Of Two Vaccines For Influenza Pandemic (H1N1) 2009
|
|
The European Medicines Agency has recommended to the European Commission that two vaccines against influenza A(H1N1) ('swine flu') be granted a marketing authorisation. Vaccines are one of the most important tools in the management of an influenza pandemic, helping to reduce illness and deaths by building up immune protection against the pandemic flu virus. To ensure that authorised vaccines are available before the start of the flu season in the coming autumn and winter months, the Agency's Committee for Medicinal Products for Human Use (CHMP) expedited its assessment.
|
|
post a Comments
|
|
|
European Medicines Agency Recommends Authorisation Of Two Vaccines For Influenza Pandemic (H1N1) 2009
|
|
The European Medicines Agency has recommended to the European Commission that two vaccines against influenza A(H1N1) ('swine flu') be granted a marketing authorisation. Vaccines are one of the most important tools in the management of an influenza pandemic, helping to reduce illness and deaths by building up immune protection against the pandemic flu virus. To ensure that authorised vaccines are available before the start of the flu season in the coming autumn and winter months, the Agency's Committee for Medicinal Products for Human Use (CHMP) expedited its assessment.
|
|
post a Comments
|
|
|
Integrated Environmental Technologies, Ltd. Announces EcaFlo(R) Anolyte (Excelyte(R)) Effective Against Swine Flu (H1N1)
|
|
Integrated Environmental Technologies, Ltd. (OTCBB: IEVM) announces the successful results of IET's EcaFlo® Anolyte solution, marketed as Excelyte®, against Swine Influenza (H1N1). Specific testing performed by Microbiotest Labs of Sterling, Virginia concluded that Excelyte® is efficacious against the microorganism which causes Swine Flu. IET will submit the results of the H1N1 testing to the EPA for inclusion on its master label.
|
|
post a Comments
|
|
|
Anti-swine flu drug FLUVIR available in India
|
|
FLUVIR, the first anti- swine flu drug, was on Tuesday launched in the retail markets across the country.
An Indian drug manufacturer, Hetero Healthcare Limited, announced the launch of FLUVIR, Oseltamivir drug similar to Tamiflu in the retail market.
The launch of the drug came at a time when the deadly virus has claimed 257 lives and affected 8,153 people in the country.
Before the government notification allowing retail sale of anti-viral drug Oseltamivir, the Centre procured 19 million FLUVIR capsules from Hetero to check the recent outbreak of deadly H1N1 flu in India, Marketing Director, Hetero Srinivas Reddy claimed.
FLUVIR, which was available only through government hospitals, will now be available in around 480 designated medical shops having Schedule X licence across the country, he said.
|
|
post a Comments
|
|
|
In Children, 2009 H1N1 Influenza Vaccine Works Like Seasonal Flu Vaccine
|
|
Early results from a trial testing a 2009 H1N1 influenza vaccine in children look promising, according to the trial sponsor, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Preliminary analysis of blood samples from a small group of trial participants shows that a single 15-microgram dose of a non-adjuvanted 2009 H1N1 influenza vaccine — the same dose that is in the seasonal flu vaccine — generates an immune response that is expected to be protective against 2009 H1N1 influenza virus in the majority of 10- to 17- year-olds eight to 10 days following vaccination. These results are similar to those recently reported in clinical trials of healthy adults. Younger children generally had a less robust early response to the vaccine.
"This is very encouraging news," says NIAID Director Anthony S. Fauci, M.D. "As we had hoped, responses to the 2009 H1N1 influenza vaccine are very similar to what we see with routinely used seasonal influenza vaccines made in the same way. It seems likely that the H1N1 flu vaccine will require just one 15-microgram dose for children 10 to 17 years of age. The 2009 H1N1 influenza virus is causing widespread infections among children, so these are welcome results."
|
|
post a Comments
|
|
|
|